• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Post-discharge Care Plans Promote Use of Primary Care

Article

Providing a solid base of primary-care service and coordinating specialty care for high-risk patients has been advocated as a method of lowering overall healthcare costs. Doing so would presumably reduce repeat hospitalization and emergency department visits.

Providing a solid base of primary-care service and coordinating specialty care for high-risk patients has been advocated as a method of lowering overall healthcare costs. Doing so would presumably reduce repeat hospitalization and emergency department visits. A new study in JAMA Internal Medicine suggests that such an approach does, indeed, work.

Researchers with University of Pennsylvania Perelman School of Medicine found that when low-income uninsured or Medicaid beneficiary patients at two Philadelphia hospitals were assisted by community health workers in developing an individual recovery plan, they were more likely to have a primary-care visit within 14 days of discharge and to report high-quality post-discharge communication.

Recently, research from the CMS Innovation Center received criticism for its lack of scientific rigor, but the University of Pennsylvania study was a randomized trial in which 222 patients received an individualized discharge plan from community health workers between April 10, 2011, and Oct. 30, 2012, and 224 who did not during that period.

Read the full story here: http://bit.ly/1h7RsCp

Source: Modern Healthcare

Related Videos
Dr Guru Sonpavde
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.